News

News
Work by ITCR investigator Anant Madabhushi (Case Western Reserve University) on developing novel computational pathology predictors for identifying cancer patients who will benefit from chemotherapy was identified as one of the top 10 medical breakthrough technologies of 2018 by Prevent Magazine! See https://www.prevention.com/health/g25423574/top-medical-breakthroughs/ 
 
 

news

Patient-derived tumor xenograft (PDX) mouse models are a versatile oncology research platform for studying tumor biology and for testing chemotherapeutic approaches tailored to genomic characteristics of individual patients’ tumors. PDX models are generated and distributed by a diverse group of academic labs, multi-institution consortia and contract research organizations.


News

Save the Date: ITCR 2019 Annual Meeting will be held in Salt Lake City/Park City, Utah, May 28-31 2019.


News

Several ITCR investigators will be attending the Radiological Society of North America (RSNA) Annual Meeting in Chicago, November 25-30, 2018. Download the schedule for the presentations by ITCR investigators.

RSNA Annual Meeting, November 25-30, 2018

Link to the Meeting Program, search by session code.


news

In this ITCR funded study Dr. Min Jin Ha and Dr. Veera Baladandayuthapani from the University of Texas MD Anderson Cancer Center and University of Michigan, assessed pan-cancer pathway activities for >7700 patients across 32 tumor types from The Cancer Proteome Atlas by developing a personalized cancer-specific integrated network estimation (PRECISE) model.

The paper can be accessed here https://www.nature.com/articles/s41598-018-32682-x


News

The Galaxy-P team (University of Minnesota, PI Tim Griffin) and the Cravat team (Johns Hopkins University, PI Rachel Karchin) have developed an automated workflow within the Galaxy for Proteomics (Galaxy-P) platform, which leverages the Cancer-Related Analysis of Variants Toolkit (CRAVAT) and makes it interoperable with proteogenomic results.


News

The NIH Common Fund Human Biomolecular Atlas Program (HuBMAP) aims to develop a framework for functional mapping the human body with cellular resolution to enhance our understanding of cellular organization-function. HuBMAP will accelerate the development of the next generation of tools and techniques to generate 3D tissue maps using validated high-content, high-throughput imaging and omics assays, and establish an open data platform for integrating, visualizing data to build multi-dimensional maps.


news

ITCR funded Cancer Deep Phenotype Extraction (DeepPhe) tool new release is now available! The tool extracts deep phenotypic information from the clinical narrative at the document-, episode-, and patient-level. The final output is FHIR compliant patient-level phenotypic summary which can be consumed by research warehouses or the DeepPhe native visualization tool. PI Dr. Guergana Savova, Boston Children's Hospital and Harvard Medical School

Release Notes


News

The next application receipt date for ITCR funding opportunities is November 20, 2018. All funding opportunties can be found here.


news

Computational DREAM Challenge to generate computational methods for extracting information from the cancer proteome and for linking those data to genomic and transcriptomic information.


news

The next application receipt date for ITCR funding opportunities is November 20, 2017. All funding opportunties can be found here.


news

New FOA for Admin Supplements to Support ITCR-IMAT Collaborations has been published! Next application due date is December 12, 2017. Pre-Application Webinar Recording and Slides